Results

Total Results: 107 records

Showing results for "4.a-2 screening".

21. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_CDS_Connect_IG_T2DM_Part_Two_Counseling_0.pdf
    January 01, 2023 - The USPSTF 2021 Gestational Diabetes Mellitus, Screening recommendation addresses screening for diabetes … a revised recommendation, “Prediabetes and Type 2 Diabetes: Screening.” … alone, and it no longer embeds screening as part of cardiovascular risk assessment. … Clinicians should consider screening earlier in persons with one or more of these.” … Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Consumer Guide.

22. Pain Management Summary Clincial Decision Support Toolkit For Repository (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
    January 01, 2003 - active) and depression (active) Pain Assessment: Wong Baker FACES completed (within past 2 years) Risk Screening … Baker FACES completed (within past 12 months) - PEG completed (more than 12 months in the past) Risk Screening … of mother O28.5 Abnormal chromosomal and genetic finding on antenatal screening of mother … pregnancy O28.0 Abnormal hematological finding on antenatal screening of mother O28.4 … Abnormal radiological finding on antenatal screening of mother O28.3 Abnormal ultrasonic finding

23. Pain Management Summary Clincial Decision Support Toolkit For Repository 0 (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - active) and depression (active) Pain Assessment: Wong Baker FACES completed (within past 2 years) Risk Screening … Baker FACES completed (within past 12 months) - PEG completed (more than 12 months in the past) Risk Screening … of mother O28.5 Abnormal chromosomal and genetic finding on antenatal screening of mother … pregnancy O28.0 Abnormal hematological finding on antenatal screening of mother O28.4 … Abnormal radiological finding on antenatal screening of mother O28.3 Abnormal ultrasonic finding

24. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - measures (eCQMs), ASCVD risk assessment tools, the Preventive Services Selector application that provides screening … aligning with current CPGs, therefore should be considered with caution and caveat: · CMS 61 – LDL Screening … (although initially considered as up to date based on the concept of screening, the numerator of this … discussed the scope of CDS that may be developed in the area of cholesterol management (i.e. supporting the screening … Diabetics · ABCS measures listed on Million Hearts website: here CDS Artifact Caution List · CMS 61 – LDL Screening

25. CDS Connect September 2021 Work Group Meeting (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/33746/CDS_Connect_WG_Presentation_September_2021.pdf
    January 01, 2021 - metadata updated with the posted IG • Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening … https://cds.ahrq.gov/cdsconnect/artifact/abnormal-blood-glucose-and-type-2-diabetes-mellitus-part-one-screening

26. 2022 Data Requirements Prediabetes And Type 2 Diabetes Part One (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2022_Data_Requirements_Prediabetes_and_Type_2_Diabetes_Part_One.xlsx
    January 01, 2022 - FHIR DSTU2 Data Requirements FHIR DSTU2 Data Requirements: Prediabetes and Type 2 Diabetes: Part 1, Screening … -9 FHIR R4 Data Requirements FHIR R4 Data Requirements: Prediabetes and Type 2 Diabetes: Part 1, Screening

27. CDS Connect Work Group June 2021 Summary (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
    January 01, 2021 - Those reviews occur at the points of prescriber knowledge, computer screening of electronic health records … (EHR), pharmacist screening, patient risk factors, drug administration, patient education, and monitoring … CDS Connect artifact examined in this WG meeting enhances risk identification during the computer screening

28. 2024 Data Requirements T2Dm Part One (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_Data_Requirements_T2DM_Part_One.xlsx
    January 01, 2024 - FHIR DSTU2 Data Requirements FHIR DSTU2 Data Requirements: Prediabetes and Type 2 Diabetes: Part 1, Screening … -9 FHIR R4 Data Requirements FHIR R4 Data Requirements: Prediabetes and Type 2 Diabetes: Part 1, Screening

29. Final Report, Year 3: CDS Connect (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
    January 01, 2019 - to as Abnormal Glucose: Screening in this document) is derived from the USPSTF full recommendation … statement on Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus. … searchresult=1 24 2.3.3 Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part … Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. … for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part 1, Screening 2.3.3 Screening for Abnormal

30. Pilot Site Training For Pain Management Summary Cds For Repository (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS%20for%20Repository.pdf
    May 24, 2023 - lowest effective dose § Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk § Urine drug screening … factors for opioid-related harms Pain Assessments – Wong-Baker FACES Rating Scale – PEG & STarT Back Screening … – MME amount – Urine drug screen results – Benzodiazepine medications – Naloxone medications – Risk screenings … Benzodiazepine medications – all within the past 2 years § Naloxone medications – ever prescribed § Risk screenings

31. 2023 Data Requirements T2Dm Part One (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_Data_Requirements_T2DM_Part_One.xlsx
    January 01, 2023 - FHIR DSTU2 Data Requirements FHIR DSTU2 Data Requirements: Prediabetes and Type 2 Diabetes: Part 1, Screening … -9 FHIR R4 Data Requirements FHIR R4 Data Requirements: Prediabetes and Type 2 Diabetes: Part 1, Screening

32. Implementation Guide: Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary50810012018.pdf
    December 01, 2018 - Patient’s risk screenings that are relevant to pain management with their overall scores and dates for … Data limitations Assessments and Screenings Much of the data in the Pain Management Summary … is comprised of assessments and screenings (e.g., Wong-Baker FACES, PEG, PHQ-9). … Many EHRs, however, do not yet support returning assessments and screenings via the FHIR API. … Decision aids for people facing health treatment or screening decisions.

33. Slide 1
    cds.ahrq.gov/sites/default/files/cds/artifact/106/Poster_AMIA_mid_atlantic_HWI_jm.pptx
    February 08, 2012 - Actual EHR documentation rates: Overweight – 13.30% Obese – 49.48% 85% of providers reported starting screening

34. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
    September 21, 2018 - lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine drug screening … factors for opioid-related harms Pain Assessments – Wong-Baker FACES Rating Scale – PEG & STarT Back Screening … MME amount – Urine drug screen results – Benzodiazepine medications – Naloxone medications – Risk screenings … Benzodiazepine medications – all within the past 2 years ▪ Naloxone medications – ever prescribed ▪ Risk screenings

35. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
    September 21, 2018 - lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine drug screening … factors for opioid-related harms Pain Assessments – Wong-Baker FACES Rating Scale – PEG & STarT Back Screening … MME amount – Urine drug screen results – Benzodiazepine medications – Naloxone medications – Risk screenings … Benzodiazepine medications – all within the past 2 years ▪ Naloxone medications – ever prescribed ▪ Risk screenings

36. Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary508_with%202020%20updates%202.pdf
    May 01, 2020 - Patient’s risk screenings that are relevant to pain management with their overall scores and dates … Much of the data in the Pain Management Summary is comprised of assessments and screenings [e.g., … Many EHRs, however, do not yet support returning assessments and screenings via the FHIR API. … issue by implementing custom code to extend their EHR's FHIR API to support returning assessments and screenings … Decision aids for people facing health treatment or screening decisions.

37. Sharing Lessons Learned with CDS Connect Template (pdf file)
    cds.ahrq.gov/sites/default/files/Sharing_Lessons_Learned_With_CDSConnect_TEMPLATE.pdf
    August 01, 2020 - Sharing Lessons Learned with CDS Connect Template SHARING LESSONS LEARNED WITH CDS: PROPOSED TOPICAL SERIES 1 508 Guidance: Quick Tips for Authors • Turn on “Accessibility Check” in PowerPoint while authoring ► Commonly found under “Review” or ”Tools”. • Gi…

38. Implementation Guide: Factors to Consider in Managing Chronic Pain (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/2023_CDS_Connect_IG_Pain_Management_Summary.pdf
    January 01, 2023 - Patient’s risk screenings that are relevant to pain management (e.g., AUDIT, DAST-10, PHQ-9) with their … support encounters. 32 Decision Category Concept Rationale Data limitations Assessments and Screenings … Much of the data in the Pain Management Summary is comprised of assessments and screenings (i.e., … Many EHRs, however, do not yet support returning assessments and screenings via the FHIR API. … Decision aids for people facing health treatment or screening decisions.

39. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    September 01, 2019 - Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: This recommendation statement was … divided into two distinct artifacts to enable implementers to select the “screening” component of the … “Hemoglobin A1c” (HbA1c) • Artifacts: Abnormal Glucose: Screening; Abnormal Glucose: Counseling. … “Gestational diabetes” • Artifacts: Abnormal Glucose: Screening; Abnormal Glucose: Counseling. … “Polycystic ovary syndrome” • Artifacts: Abnormal Glucose: Screening; Abnormal Glucose: Counseling

40. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    January 01, 2019 - Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: This recommendation statement was … divided into two distinct artifacts to enable implementers to select the “screening” component of the … “Hemoglobin A1c” (HbA1c) • Artifacts: Abnormal Glucose: Screening; Abnormal Glucose: Counseling. … “Gestational diabetes” • Artifacts: Abnormal Glucose: Screening; Abnormal Glucose: Counseling. … “Polycystic ovary syndrome” • Artifacts: Abnormal Glucose: Screening; Abnormal Glucose: Counseling